FDA-Drug2022-08-10Class I
SUSTANGO (Pendenadril Tytrate Blend) Capsules, 400 mg, 10-count blisters per carton, Formulated by: Male FX Labs, Bangor, ME, ASIN X0024468I9.
Ultra Supplement LLC
Hazard
Marketed Without an Approved NDA/ANDA: Analytical testing showed the presence of tadalafil.
Sold states
Product was distributed nationwide in the USA via Amazon Marketplace on www.amazon.com.
Affected count
750 cartons
Manufactured in
1007 N Market St, N/A, Wilmington, DE, United States
Products
SUSTANGO (Pendenadril Tytrate Blend) Capsules, 400 mg, 10-count blisters per carton, Formulated by: Male FX Labs, Bangor, ME, ASIN X0024468I9.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1350-2022Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief